Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595486 · ClinicalTrials.gov registry record · NA
Baby2Home (B2H) Mobile Health Application
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 642
- Enrollment target
NCT05595486 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 642 participants.
The verdict
NCT05595486, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 642 participants
- Enrollment target
Study Summary
The COVID-19 pandemic has transformed healthcare delivery; arguably, the fields of obstetrics and pediatrics have experienced some of the greatest changes as they have transitioned away from their role as a medical home and into more of an urgent care model of care. Baby2Home is a digital health intervention designed to bridge the resultant gaps in obstetrics and pediatrics healthcare services for new families over the first year of life. This randomized controlled trial will evaluate whether, compared to usual care, Baby2Home 1) improves maternal, paternal, and infant health service utilization outcomes over the first year postpartum, 2) improves maternal and paternal patient reported outcomes, and 3) reduces racial/ethnic and income-based disparities in preventive health services utilization and parental patient reported outcomes.
Interventions
- OTHER Baby2Home Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2022-11-09 |
| Est. Completion | 2025-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05595486
The ClinicalTrials.gov registry entry for NCT05595486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baby2Home Mobile Application is the first listed.
NCT05595486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05595486 about?
NCT05595486 is a clinical study titled "Baby2Home (B2H) Mobile Health Application". The COVID-19 pandemic has transformed healthcare delivery; arguably, the fields of obstetrics and pediatrics have experienced some of the greatest changes as they have transitioned away from their role as a medical home and into more of an urgent care model of care. Baby2Home is a digital health int...
What is the current status of trial NCT05595486?
This trial is currently completed. It is a NA study. The enrollment target is 642 participants. The study started on 2022-11-09. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT05595486?
The interventions under investigation include: Baby2Home Mobile Application (OTHER).
Who is sponsoring clinical trial NCT05595486?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.